Walleye Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Walleye Capital's DGX Position: Q3 2026 in Review
Walleye Capital increased its Quest Diagnostics (DGX) stake by 8,628% in Q3 2026, buying an estimated $1.76M and bringing the position to 7,681 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2933.
Walleye Capital first reported a position in DGX in Q2 2019 and has held it in 13 quarters since. The position peaked at $2.79M in Q4 2025. 1,134 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Walleye Capital held 7,681 shares of Quest Diagnostics worth $1.79M as of Q3 2026.
- Walleye Capital bought 7,593 Quest Diagnostics shares in Q3 2026, an estimated $1.76M.
- Quest Diagnostics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2933 holding.
- Walleye Capital first reported a position in Quest Diagnostics in Q2 2019 and has held it in 13 quarters since.
- Walleye Capital's Quest Diagnostics position peaked at $2.79M in Q4 2025.
- 1,134 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.